Browse articles from EyeWorld.org related to the retina. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
ASCRS EyeWorld Weekly: View the current issue ➤ Claes Dohlman, MD, PhD, dies at 101 years old ➤ Trial to evaluate neuropathic corneal pain drug ➤ FDA clears new OCT technology ➤ Study: supplements slow progression of late-stage dry AMD ➤ Young eye surgeon scholarship opportunity ➤ Acquisition news ➤ ASCRS news and events
➤ FDA grants De Novo classification to ocular pressure adjusting pump ➤ Inaugural ‘State of Dry Eye’ survey ➤ Study: potentially higher risk for blinding ocular condition with semaglutide use ➤ Wet AMD treatment implant reintroduced ➤ Acquisition news ➤ ASCRS news and events
➤ Prospective trial reveals impact of home OCT in wet AMD management ➤ Devices receive FDA 510(k) clearance ➤ Review date set for BLA for treatment of macular telangiectasia type 2 ➤ FDA grants IND to gene therapy for patients with geographic atrophy ➤ Acquisition news ➤ ASCRS news and events
➤ Allogenic cell therapy receives FDA designations ➤ Robot delivers new treatment for wet AMD ➤ Health-related quality of life measure proposed for MIGS ➤ Company meets with FDA for pediatric myopia drug candidate ➤ ASCRS news and events
➤ 52-week Phase 3 data published for cyclosporine, 0.1% ➤ First patient enrolled in Phase 3 trial assessing new treatment for MGD ➤ Geographic atrophy treatment trial advances to highest dose ➤ New dataset added to support various areas of research and development ➤ ASCRS news and events
➤ Twelve-month results for Phase 2 trial evaluating heat-therapy system for MGD ➤ Topline results from targeted photobiomodulation for treatment of progressive myopia ➤ Enrollment complete in Phase 3 trials to evaluate new wet AMD therapy ➤ ‘Low tech’ way to prioritize cataract surgery ➤ ASCRS news and events
➤ FDA grants 510(k) indication expansion for MIGS tool ➤ FDA approves biosimilar for aflibercept ➤ De Novo Marketing Authorization granted for home OCT device ➤ Consensus guidelines for suprachoroidal drug delivery ➤ ASCRS news and events
➤ Topline results for investigational first-in-class dry eye drop ➤ Dosing complete in second cohort of Stargardt disease gene therapy trial ➤ Enrollment complete for Phase 2 acute optic neuritis trial ➤ Enrollment complete for Phase 1/2a trial evaluating neovascular AMD therapy ➤ ASCRS news and events
➤ CRISPR gene-editing trial shows ‘exciting potential’ ➤ Study: laser vision correction clinics missing opportunities ➤ Broad-based protection observed with investigational geographic atrophy therapy ➤ FDA accepts IND for diabetic macular edema therapy ➤ Phase 2 trial for non-proliferative diabetic retinopathy therapy does not meet primary endpoint ➤ ASCRS news and events
➤ FDA clears fully autonomous, portable AI device for diabetic retinopathy screening ➤ Positive preliminary data for Phase 1/2 trial evaluating gene therapy treatment for X-linked retinoschisis ➤ Dosing in Phase 1/2 trial for allogenic cell therapy for corneal edema ➤ Dosing complete in trial assessing corneal edema therapy ➤ Phase 4 results for mydriasis product reported ➤ Collaboration seeks to commercialize Alzheimer’s detection through retinal imaging ➤ ASCRS news and events